BDE 47

Overview

BDE 47 targets mitochondria, inhibits mitochondrial oxidative phosphorylation ( OXPHOS ), decreases mitochondrial membrane potential ( MMP ) and induces apoptosis in embryonic cell. BDE 47 induces the generation of ROS , and activates the JNK signaling pathway. BDE 47 exhibits embryonic developmental toxicity in zebrafish.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Oxidative Phosphorylation | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > JNK

Product Information

• Catalog No.: HY-W762011
• CAS No.: 5436-43-1
• Molecular Formula: C12H6Br4O
• Molecular Weight: 485.79
• Purity: 98.65%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (10.29 mM); Clear solution
• Availability: In-stock

Source

Original product source